Survival rates of Spectron clarified:
This article was originally published in Clinica
Smith & Nephew has pointed out that reference to Spectron's performance in the Swedish study on hip revisions reported in Clinica No 706, p 5 relates to the metal-backed implant. The current version of the Spectron hip - the All-Poly - had the highest survival rate of all hips included in the study. The nine-year survival rate for the All-Poly version was 99.2% (in 939 patients) compared with 87.9% for the metal-backed version (1,362 patients).
You may also be interested in...
To be more transparent and allow more public discourse, the HHS now requires all its agencies to publish documents it uses to rationalize proposed rules and demonstration projects.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.